First National Bank Of South Miami Vertex Pharmaceuticals Inc Transaction History

First National Bank Of South Miami

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 12, 2023	SELL	$285.76 - $321.48 $2,857 - $3,214	-10 Reduced 13.89%	62 $18,000
Q3 2022 Oct 31, 2022	SELL	$273.83 - $305.53 $7,393 - $8,249	-27 Reduced 27.27%	72 $21,000
Q2 2022 Jul 13, 2022	SELL	$234.96 - $292.55 $10,103 - $12,579	-43 Reduced 30.28%	99 $28,000
Q1 2022 Apr 08, 2022	SELL	$221.42 - $260.97 $4,428 - $5,219	-20 Reduced 12.35%	142 $37,000
Q4 2021 Jan 18, 2022	SELL	$177.01 - $223.45 $6,195 - $7,820	-35 Reduced 17.77%	162 $36,000
Q3 2021 Oct 07, 2021	BUY	$181.39 - $202.99 $5,985 - $6,698	33 Added 20.12%	197 $36,000
Q2 2021 Jul 13, 2021	SELL	$187.49 - $221.1 $14,999 - $17,688	-80 Reduced 32.79%	164 $33,000
Q1 2021 May 11, 2021	BUY	$207.02 - $241.31 $50,512 - $58,879	244 New	244 $52,000

1,716

225M

1.19M

1.56M

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $129B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

Get notified when there are updates to the investment portfolio of First National Bank Of South Miami, based on Form 13F filings with the SEC.

Stay updated on First National Bank Of South Miami with notifications on news.